ST. LOUIS – Saint Louis University is looking for people to participate in a new study gauging the risk of a severe allergic reaction (anaphylaxis) to the Pfizer and Moderna COVID vaccines.
SLU is collaborating on this effort with about 30 other sites.
Participants are randomly assigned to receive the Pfizer vaccine, Moderna vaccine or a placebo followed by a vaccine.
In the end, all participants will receive the two full doses of either the Pfizer or Moderna COVID vaccines.
Those conducting the study are allergists who are trained to recognize and treat anaphylaxis.
Those in the study will be “observed for at least 90 minutes after each injection in case any type of reaction occurs,” according to Saint Louis University.
Click here to learn more about the study. People who are interested in learning more about the study can call SLU’s Center for Vaccine Development at 314-977-6333 to learn more.